PRQR

PROQR THRAPEUTICS N V

PRQR·N71542109·US·Common Stock·Healthcare - Biotechnology-Activist

PRQR (PROQR THRAPEUTICS N V) is held by 31 institutional investors as of Q2 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($16.8M), Aberdeen Group plc ($16.6M), Woodline Partners LP ($6.1M). Net institutional sentiment: Mixed.

31
Holders
$53.3M
Total Value
55% (29)
Consensus
16 buying - 13 selling
13F: Insider & Congress: Updated regularly
PRQR

Smart Money Verdict

View all
Loading verdict
Held by 31 funds

Who's Trading

Source dates: Price Oct 15, 2026 · Insiders Aug 3, 2026 · Activists Jul 29, 2026 · Congress none

InsiderDAde Boer Daniel AntonBuy $354KJul 31, 2026
ActivistVHVan Herk Investments B.V.10.9%Jul 29, 2026
ActivistAberdeen Group plcAberdeen Group plc6.3%Jul 29, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
9M(+44.2%)$16.8M0.0%-72.04%
38
Increased
8.9M(+169.3%)$16.6M0.0%-18.39%
46
New
3.3M$6.1M0.0%-22.04%
38
Increased
1.8M(+36.0%)$3.3M0.0%-22.43%
34
Increased
1.2M(+68.4%)$2.2M0.0%-24.28%
38
Increased
1.1M(+23.9%)$2.1M0.0%-29.38%
32
Increased
639,243(+109.4%)$1.2M0.0%-26.16%
41
Unchanged
620,000$1.2M0.0%-27.50%
0
Increased
571,073(+4.6%)$1.1M0.0%-24.53%
26
Increased
455,104(+1267.1%)$846,4930.0%-22.38%
40
Increased
275,631(+59.9%)$512,6740.0%-24.42%
35
Decreased
161,004(-17.1%)$299,4670.0%-38.23%
0
Unchanged
108,762$202,2970.0%-26.77%
0
Unchanged
85,000$158,1000.0%-24.27%
0
Increased
84,806(+604.7%)$157,7390.0%-23.25%
36
Decreased
58,040(-68.7%)$107,9540.0%-30.96%
0
Decreased
57,997(-31.7%)$107,8740.0%-71.26%
0
Decreased
50,652(-93.3%)$94,2130.0%-44.21%
0
Increased
39,954(+44.5%)$74,3140.0%-20.61%
29
Increased
35,241(+2610.8%)$65,5480.0%-22.79%
34

Showing 1-20 of 39

1 / 2
PRQRPRQRPROQR THRAPEUTICS N V

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used